{"id":"https://openalex.org/W2586897736","doi":"https://doi.org/10.1158/1535-7163.mct-16-0613","title":"Lipid Nanoparticle\u2013Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth","display_name":"Lipid Nanoparticle\u2013Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth","publication_year":2017,"publication_date":"2017-02-06","ids":{"openalex":"https://openalex.org/W2586897736","doi":"https://doi.org/10.1158/1535-7163.mct-16-0613","mag":"2586897736","pmid":"https://pubmed.ncbi.nlm.nih.gov/28167506"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-16-0613","doi":"https://doi.org/10.1158/1535-7163.mct-16-0613","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-16-0613","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029742452","display_name":"Xinqiang Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xinqiang Huang","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040403592","display_name":"Jill Magnus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jill Magnus","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102749316","display_name":"Vivek Kaimal","orcid":"https://orcid.org/0000-0003-0268-2642","observed_orcids":["https://orcid.org/0000-0003-0268-2642"]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivek Kaimal","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005125907","display_name":"Priya Prakash Karmali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priya Karmali","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100402448","display_name":"Jian Li","orcid":"https://orcid.org/0000-0001-9434-7803","observed_orcids":["https://orcid.org/0000-0001-9434-7803"]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jian Li","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026543504","display_name":"Marlena Walls","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marlena Walls","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006279759","display_name":"Rene Y. Prudente","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rene Prudente","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eric Sung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Sung","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015124019","display_name":"Mehran Sorourian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehran Sorourian","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057303695","display_name":"Robin Lee","orcid":"https://orcid.org/0000-0001-7209-3929","observed_orcids":["https://orcid.org/0000-0001-7209-3929"]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Lee","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063891636","display_name":"Scott P. Davis","orcid":"https://orcid.org/0000-0001-5320-4435","observed_orcids":["https://orcid.org/0000-0001-5320-4435"]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Davis","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xia Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xia Yang","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034065188","display_name":"Heather Estrella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather Estrella","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084463445","display_name":"Edmund Chun Yu Lee","orcid":"https://orcid.org/0000-0001-5843-247X","observed_orcids":["https://orcid.org/0000-0001-5843-247X"]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edmund C. Lee","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108359400","display_name":"B. Nelson Chau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Nelson Chau","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055212394","display_name":"Adam Pavl\u00ed\u010dek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Pavlicek","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111904185","display_name":"Sonya Zabludoff","orcid":"https://orcid.org/0000-0003-1786-6241","observed_orcids":["https://orcid.org/0000-0003-1786-6241"]},"institutions":[{"id":"https://openalex.org/I111532955","display_name":"Regulus Therapeutics (United States)","ror":"https://ror.org/03ey7ve44","country_code":"US","type":"company","lineage":["https://openalex.org/I111532955"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonya Zabludoff","raw_affiliation_strings":["Regulus Therapeutics Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulus Therapeutics Inc., San Diego, California","institution_ids":["https://openalex.org/I111532955"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I111532955"],"apc_list":null,"apc_paid":null,"fwci":1.11,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.71631987,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"16","issue":"5","first_page":"905","last_page":"913"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.6470000147819519,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.6470000147819519,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.34860000014305115,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10515","display_name":"Cancer-related molecular mechanisms research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9599999785423279},{"id":"https://openalex.org/keywords/mir-17-family","display_name":"miR-17 family","score":0.9959999918937683},{"id":"https://openalex.org/keywords/anti-mir-oligonucleotides","display_name":"anti-miR oligonucleotides","score":0.8090000152587891},{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.7910000085830688},{"id":"https://openalex.org/keywords/microrna-inhibition","display_name":"microRNA inhibition","score":0.7059999704360962},{"id":"https://openalex.org/keywords/tgf-beta-signaling","display_name":"TGF-beta signaling","score":0.6600000262260437},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6990000009536743},{"id":"https://openalex.org/keywords/microrna-target-genes","display_name":"miRNA target genes","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6402546167373657},{"id":"https://openalex.org/C149150037","wikidata":"https://www.wikidata.org/wiki/Q554446","display_name":"Bcl-2 family","level":4,"score":0.5957562327384949},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.58502197265625},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5213452577590942},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.5168662667274475},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5028199553489685},{"id":"https://openalex.org/C5911399","wikidata":"https://www.wikidata.org/wiki/Q2278983","display_name":"Gene family","level":4,"score":0.4518990218639374},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42498356103897095},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4227929711341858},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.39547157287597656},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.33929893374443054},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.20408710837364197},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.15613442659378052},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15398338437080383}],"mesh":[{"descriptor_ui":"D000070416","descriptor_name":"Antagomirs","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000070416","descriptor_name":"Antagomirs","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D035683","descriptor_name":"MicroRNAs","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D035683","descriptor_name":"MicroRNAs","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D035683","descriptor_name":"MicroRNAs","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D056945","descriptor_name":"Hep G2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063646","descriptor_name":"Carcinogenesis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-16-0613","doi":"https://doi.org/10.1158/1535-7163.mct-16-0613","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-16-0613","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:28167506","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28167506","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W1542927170","https://openalex.org/W1648301895","https://openalex.org/W1966851131","https://openalex.org/W1967434897","https://openalex.org/W1973614663","https://openalex.org/W1977372263","https://openalex.org/W1987851658","https://openalex.org/W1988188075","https://openalex.org/W1992935306","https://openalex.org/W1994762365","https://openalex.org/W2000961142","https://openalex.org/W2008945738","https://openalex.org/W2026570544","https://openalex.org/W2029065593","https://openalex.org/W2033595939","https://openalex.org/W2038625523","https://openalex.org/W2043051628","https://openalex.org/W2051190668","https://openalex.org/W2072886988","https://openalex.org/W2083381199","https://openalex.org/W2084096499","https://openalex.org/W2088199884","https://openalex.org/W2092035608","https://openalex.org/W2093073599","https://openalex.org/W2095949640","https://openalex.org/W2106787323","https://openalex.org/W2121629705","https://openalex.org/W2126914449","https://openalex.org/W2128520557","https://openalex.org/W2133419523","https://openalex.org/W2134874720","https://openalex.org/W2137094308","https://openalex.org/W2141458291","https://openalex.org/W2143145944","https://openalex.org/W2144971212","https://openalex.org/W2145220982","https://openalex.org/W2146512944","https://openalex.org/W2148083746","https://openalex.org/W2149896139","https://openalex.org/W2164455778","https://openalex.org/W2166499722","https://openalex.org/W2169456326","https://openalex.org/W2415225663","https://openalex.org/W2917837889","https://openalex.org/W6679652433"],"related_works":["https://openalex.org/W2767788839","https://openalex.org/W4321787802","https://openalex.org/W2594245942","https://openalex.org/W4362661794","https://openalex.org/W2626632194","https://openalex.org/W2767726612","https://openalex.org/W2034402063","https://openalex.org/W2076278549","https://openalex.org/W2485498491","https://openalex.org/W1988836499"],"abstract_inverted_index":{"Abstract":[0],"Hepatocellular":[1],"carcinoma":[2],"(HCC)":[3],"is":[4],"one":[5],"of":[6,22,25,40,47,70,87,99,108,111,123,171,188,203],"the":[7,26,48,62,85,94,100,112,124,129,172,215],"most":[8],"common":[9],"human":[10],"malignancies":[11],"with":[12,132,201],"poor":[13],"prognosis":[14],"and":[15,34,73,76,89,141,152,196],"urgent":[16],"unmet":[17],"medical":[18],"need.":[19],"Aberrant":[20],"expression":[21],"multiple":[23],"members":[24],"miR-17":[27,49,63,95,101,145,173,204,216],"family":[28,50,64,102,113,146,164,174,205,217],"are":[29],"frequently":[30],"observed":[31,195],"in":[32,67,114,139,192,218],"HCC,":[33],"their":[35],"overexpression":[36],"promotes":[37],"tumorigenic":[38],"properties":[39],"HCC":[41,52,71,117,177,219],"cells.":[42,143],"However,":[43],"whether":[44,168],"pharmacologic":[45,169],"inhibition":[46,78,98,199],"inhibits":[51],"growth":[53,86,191,198],"remains":[54],"unknown.":[55],"In":[56],"this":[57,209],"study,":[58],"we":[59],"validated":[60],"that":[61,128],"was":[65,150,180,194],"upregulated":[66],"a":[68,80,105,157,161],"subset":[69],"tumors":[72],"cell":[74,118],"lines":[75,119],"its":[77],"by":[79],"tough":[81],"decoy":[82],"inhibitor":[83],"suppressed":[84],"Hep3B":[88,140,185,189],"HepG2":[90,142],"cells,":[91],"which":[92],"overexpress":[93],"family.":[96],"Furthermore,":[97],"led":[103],"to":[104,154,183],"global":[106],"derepression":[107],"direct":[109],"targets":[110],"all":[115],"three":[116],"tested.":[120],"Pathway":[121],"analysis":[122],"deregulated":[125],"genes":[126,130],"indicated":[127],"associated":[131],"TGF\u03b2":[133],"signaling":[134],"pathway":[135],"were":[136],"highly":[137],"enriched":[138],"A":[144],"target":[147,206],"gene":[148],"signature":[149],"established":[151],"used":[153],"identify":[155],"RL01-17(5),":[156],"lipid":[158],"nanoparticle":[159],"encapsulating":[160],"potent":[162],"anti-miR-17":[163],"oligonucleotide.":[165],"To":[166],"address":[167],"modulation":[170],"can":[175],"inhibit":[176],"growth,":[178],"RL01-17(5)":[179],"systemically":[181],"administrated":[182],"orthotopic":[184],"xenografts.":[186],"Suppression":[187],"tumor":[190,197],"vivo":[193],"correlated":[200],"induction":[202],"genes.":[207],"Together,":[208],"study":[210],"provides":[211],"proof-of-concept":[212],"for":[213],"targeting":[214],"therapy.":[220],"Mol":[221],"Cancer":[222],"Ther;":[223],"16(5);":[224],"905\u201313.":[225],"\u00a92017":[226],"AACR.":[227]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2017-02-17T00:00:00"}